EE9900497A - Söögiisu pärssiva toimega farmatseutilised kompositsioonid - Google Patents
Söögiisu pärssiva toimega farmatseutilised kompositsioonidInfo
- Publication number
- EE9900497A EE9900497A EEP199900497A EEP9900497A EE9900497A EE 9900497 A EE9900497 A EE 9900497A EE P199900497 A EEP199900497 A EE P199900497A EE P9900497 A EEP9900497 A EE P9900497A EE 9900497 A EE9900497 A EE 9900497A
- Authority
- EE
- Estonia
- Prior art keywords
- pharmaceutical compositions
- appetite suppressant
- suppressant action
- action
- appetite
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/33—Cactaceae (Cactus family), e.g. pricklypear or Cereus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/04—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
- C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
- C07H5/10—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J17/005—Glycosides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
- C07J7/0035—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a hydroxy group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
- C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Polymers & Plastics (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA973201 | 1997-04-15 | ||
| PCT/GB1998/001100 WO1998046243A2 (en) | 1997-04-15 | 1998-04-15 | Pharmaceutical compositions having appetite suppressant activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9900497A true EE9900497A (et) | 2000-06-15 |
Family
ID=25586362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900497A EE9900497A (et) | 1997-04-15 | 1998-04-15 | Söögiisu pärssiva toimega farmatseutilised kompositsioonid |
Country Status (40)
| Country | Link |
|---|---|
| US (6) | US6376657B1 (et) |
| EP (5) | EP1438965A1 (et) |
| JP (3) | JP3553086B2 (et) |
| KR (2) | KR100510614B1 (et) |
| CN (3) | CN101239090A (et) |
| AP (3) | AP2003002730A0 (et) |
| AT (3) | ATE344046T1 (et) |
| AU (1) | AU746414B2 (et) |
| BG (1) | BG103795A (et) |
| BR (1) | BR9808593A (et) |
| CA (2) | CA2584411A1 (et) |
| DE (3) | DE69840552D1 (et) |
| DK (1) | DK0973534T3 (et) |
| EA (2) | EA200200392A1 (et) |
| EE (1) | EE9900497A (et) |
| ES (3) | ES2363230T3 (et) |
| GB (3) | GB2338235B (et) |
| GE (2) | GEP20022709B (et) |
| GT (3) | GT199800076BA (et) |
| HK (1) | HK1026373A1 (et) |
| HU (1) | HUP0000838A3 (et) |
| ID (1) | ID22888A (et) |
| IL (3) | IL131659A (et) |
| IS (1) | IS5196A (et) |
| MY (1) | MY141674A (et) |
| NO (1) | NO994992L (et) |
| NZ (5) | NZ516696A (et) |
| OA (1) | OA11166A (et) |
| PE (1) | PE85699A1 (et) |
| PL (3) | PL201487B1 (et) |
| PT (2) | PT1213020E (et) |
| SA (1) | SA98190501B1 (et) |
| SG (1) | SG120054A1 (et) |
| SK (1) | SK141899A3 (et) |
| TR (2) | TR200001846T2 (et) |
| TW (3) | TW589187B (et) |
| UA (1) | UA72439C2 (et) |
| WO (1) | WO1998046243A2 (et) |
| YU (1) | YU52199A (et) |
| ZA (1) | ZA983170B (et) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0000838A3 (en) * | 1997-04-15 | 2001-04-28 | Csir | Extract containing steroid-glucosid, process for its isolation and synthesis, pharmaceutical composition containing it having appetite suppressant activity |
| EP1204645A2 (en) * | 1999-08-04 | 2002-05-15 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
| GB2355657B (en) | 1999-10-27 | 2004-07-28 | Phytopharm Plc | Inhibitors Of Gastric Acid Secretion |
| GB2363985B (en) * | 2000-06-30 | 2004-09-29 | Phytopharm Plc | Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use |
| JP4181035B2 (ja) * | 2001-07-19 | 2008-11-12 | アビザ ヨーロッパ リミティド | タンタル膜の堆積 |
| JP4570874B2 (ja) | 2001-11-16 | 2010-10-27 | ネステク ソシエテ アノニム | 植物から誘導されるか又は誘導し得る食欲抑制活性を有する物質 |
| US20040265398A1 (en) * | 2002-04-25 | 2004-12-30 | Fleischner Albert M. | Herbal composition for weight control |
| US20060233861A1 (en) * | 2003-02-14 | 2006-10-19 | Maclean David B | Modulation of atp production or content in the hypothalamus |
| US7060308B2 (en) * | 2003-06-04 | 2006-06-13 | Ramaswamy Rajendran | Caralluma extract products and processes for making the same |
| US7976880B2 (en) * | 2003-06-04 | 2011-07-12 | Ramaswamy Rajendran | Pregnane glycoside compositions and Caralluma extract products and uses thereof |
| CA2563237C (en) * | 2004-04-07 | 2012-10-09 | Rutgers, The State University Of New Jersey | Appetite-suppressing compositions and methods |
| GB0411703D0 (en) * | 2004-05-25 | 2004-06-30 | Phytopharm Plc | Selective separation or extraction of steroidal glycosides |
| US20050276839A1 (en) * | 2004-06-10 | 2005-12-15 | Rifkin Calman H | Appetite satiation and hydration beverage |
| US20050276869A1 (en) * | 2004-06-14 | 2005-12-15 | Century Systems | Appetite-suppressing, lipase-inhibiting herbal composition |
| US7500679B2 (en) * | 2004-10-08 | 2009-03-10 | Wade James T | Board for supporting front of snow vehicle |
| US20060083795A1 (en) * | 2004-10-19 | 2006-04-20 | Lima Shatkina | Meal replacement products having appetite suppressing qualities |
| GB0425172D0 (en) * | 2004-11-15 | 2004-12-15 | Phyto Res Ltd | Plant cells and uses thereof |
| WO2006079056A1 (en) * | 2005-01-20 | 2006-07-27 | Stephen Holt | Herbal compositions containing hoodia |
| AU2006279602B2 (en) * | 2005-08-17 | 2009-06-04 | Elc Management Llc | Delivery system for appetite suppressant |
| US20070082115A1 (en) * | 2005-10-07 | 2007-04-12 | Aimutis William Ronald Jr | Methods for inducing satiety, reducing food intake and reducing weight |
| US20070082108A1 (en) * | 2005-10-07 | 2007-04-12 | Aimutis William R Jr | Methods for reducing calorie intake |
| US20070082025A1 (en) * | 2005-10-07 | 2007-04-12 | Catani Steven J | Methods for achieving and maintaining weight loss |
| US20070082084A1 (en) * | 2005-10-07 | 2007-04-12 | Catani Steven J | Methods for weight management |
| US20070082030A1 (en) * | 2005-10-07 | 2007-04-12 | Aimutis William R | Fiber satiety compositions |
| US20070082029A1 (en) * | 2005-10-07 | 2007-04-12 | Aimutis William R | Fiber satiety compositions |
| US20070082028A1 (en) * | 2005-10-07 | 2007-04-12 | Aimutis William R Jr | Compositions and methods for inducing satiety and reducing caloric intake |
| US20070082114A1 (en) * | 2005-10-07 | 2007-04-12 | Catani Steven J | Methods for reducing weight |
| US20070082026A1 (en) * | 2005-10-07 | 2007-04-12 | Aimutis William R Jr | Compositions and methods for reducing food intake and controlling weight |
| US20070082085A1 (en) * | 2005-10-07 | 2007-04-12 | Catani Steven J | Compositions and methods for reducing food intake and controlling weight |
| US20070104805A1 (en) * | 2005-11-01 | 2007-05-10 | Udell Ronald G | Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives |
| US8945652B2 (en) | 2005-11-23 | 2015-02-03 | The Coca-Cola Company | High-potency sweetener for weight management and compositions sweetened therewith |
| US20070207227A1 (en) * | 2006-02-23 | 2007-09-06 | Conopco, Inc., D/B/A Unilever, A Corporation Of New York | Appetite suppressant compositions |
| US20070196436A1 (en) * | 2006-02-23 | 2007-08-23 | Conopco, Inc., D/B/A Unilever | Process for preparing an edible composition comprising steroidal glycosides |
| BRPI0711240A2 (pt) * | 2006-06-13 | 2011-08-30 | Unilever Nv | produto de proção única e método para a supressão do apetite |
| JP5281234B2 (ja) * | 2006-06-27 | 2013-09-04 | ポーラ化成工業株式会社 | 毛様体過緊張による疲れ目の改善・予防のための経口投与組成物 |
| CA2660464A1 (en) | 2006-08-17 | 2008-02-21 | Unilever Plc | Processes for production of hoodia plant extracts containing steroidal glycosides |
| CA2661593A1 (en) * | 2006-08-24 | 2008-02-28 | Unilever Plc | Process for preparing a composition comprising steroidal glycosides |
| US20080085354A1 (en) * | 2006-10-06 | 2008-04-10 | Teresa Marie Paeschke | Controlled hydration of hydrocolloids |
| US20080138447A1 (en) * | 2006-12-06 | 2008-06-12 | Erin John Riggins | Method for administering appetite suppressant and composition thereof |
| AU2007336412A1 (en) * | 2006-12-21 | 2008-06-26 | Unilever Plc | Process for harvesting plants of the Apocynaceae family |
| US20080188447A1 (en) * | 2007-02-02 | 2008-08-07 | Svyatoslav Komarnytsky | Glucocorticoid-lowering composition |
| US8580236B2 (en) * | 2007-03-19 | 2013-11-12 | Richard P. De Maria | Hair sustaining formulation |
| EP2052727A3 (en) * | 2007-10-02 | 2010-06-02 | Unilever N.V. | Hoodia extract oil compositions comprising unsaturated monoacylglycerides |
| US20100316736A1 (en) * | 2007-10-24 | 2010-12-16 | Desert Labs Agriculture Cooperative Association Ltd. | Appetite suppressant |
| US20090110774A1 (en) * | 2007-10-26 | 2009-04-30 | The Hershey Company | High antioxidant levels in cocoa-based beverages |
| ATE502620T1 (de) | 2007-11-17 | 2011-04-15 | Cognis Ip Man Gmbh | Verfahren zur herstellung von wirkstoffkonzentraten |
| EP2080517A1 (en) | 2008-01-18 | 2009-07-22 | Unilever N.V. | Process for obtaining dried plant material |
| US20090324757A1 (en) * | 2008-03-31 | 2009-12-31 | Rutgers, The State University Of New Jersey | Compositions and Methods for Modulating Visceral Sensation and/or Gastrointestinal Reflex Activity |
| JP5276885B2 (ja) * | 2008-04-11 | 2013-08-28 | 株式会社耐熱性酵素研究所 | キチン又はキトサンを含む分解性複合材料 |
| US20090263510A1 (en) * | 2008-04-21 | 2009-10-22 | Conopco, Inc., D/B/A Unilever | Process of making Hoodia plant extract with improved flavor |
| US7923435B2 (en) | 2008-04-21 | 2011-04-12 | Phytopharm Plc | Hoodia plant extract with improved flavor |
| WO2010067355A1 (en) | 2008-12-08 | 2010-06-17 | Hadasit Medical Research Services & Development Ltd. | Method of treatment of diseases using hoodia extracts |
| WO2011001283A2 (en) | 2009-07-01 | 2011-01-06 | Natures Remedies Ltd. | Composition and method for reducing food intake |
| EP2329836A1 (en) | 2009-12-03 | 2011-06-08 | I.R.B. Istituto Di Ricerche Biotecnologiche S.r.l. | Extracts obtained from hoodia gordonii cells lines, their preparation and use |
| MX2012009539A (es) * | 2010-02-18 | 2012-10-01 | Hershey Co | Bebidas para la recuperacion del ejercicio a base de cacao. |
| WO2012022880A2 (fr) | 2010-07-29 | 2012-02-23 | Universite De Strasbourg | Procede de synthese de steroïdes |
| CN102462690B (zh) * | 2010-11-11 | 2013-04-17 | 中国科学院上海药物研究所 | 3，8，12，14，17，20位氧取代孕甾烯糖苷类化合物在制备抑制食欲的药物中的用途 |
| JP6114695B2 (ja) | 2010-12-20 | 2017-04-12 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 満腹応答を誘導するためのペットフード組成物 |
| SG10201607085WA (en) | 2011-01-07 | 2016-10-28 | Elcelyx Therapeutics Inc | Chemosensory Receptor Ligand-Based Therapies |
| US9795792B2 (en) | 2011-02-25 | 2017-10-24 | Medtronic, Inc. | Emergency mode switching for non-pacing modes |
| JP6175074B2 (ja) | 2012-01-06 | 2017-08-02 | エルセリクス セラピューティクス インコーポレイテッド | 代謝障害を治療するための組成物および方法 |
| BR112014016808B1 (pt) | 2012-01-06 | 2022-01-11 | Anji Pharma (Us) Llc | Uso de um composto de biguanida para a fabricação de um medicamento para baixar os níveis de glicose no sangue e para o tratamento de um distúrbio do metabolismo de glicose |
| US9456916B2 (en) | 2013-03-12 | 2016-10-04 | Medibotics Llc | Device for selectively reducing absorption of unhealthy food |
| EP2872127A1 (en) | 2012-07-11 | 2015-05-20 | Elcelyx Therapeutics, Inc. | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
| CA2896864C (en) | 2013-01-05 | 2021-04-20 | Elcelyx Therapeutics, Inc. | Delayed-release composition comprising biguanide |
| US9011365B2 (en) | 2013-03-12 | 2015-04-21 | Medibotics Llc | Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food |
| US9067070B2 (en) | 2013-03-12 | 2015-06-30 | Medibotics Llc | Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type |
| WO2014194068A1 (en) * | 2013-05-29 | 2014-12-04 | Northeastern University | Glycosylated cardiotonic steroids |
| CN103755762B (zh) * | 2014-01-30 | 2016-06-01 | 中国科学院上海有机化学研究所 | 果同尼皂苷f及其衍生物的中间体、制备方法和用途及果同尼皂苷f衍生物 |
| GB2544416B (en) | 2015-11-13 | 2017-11-01 | Lykke Res Ltd | A method for producing a medium containing steroidal glycosides from plant cells of the genus Hoodia |
Family Cites Families (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4062950A (en) * | 1973-09-22 | 1977-12-13 | Bayer Aktiengesellschaft | Amino sugar derivatives |
| FR2348655A1 (fr) | 1976-04-20 | 1977-11-18 | Sopharga Lab | Nouvelle substance alimentaire ou dietetique ayant une structure alveolaire et son procede de preparation |
| US4185116A (en) | 1976-09-28 | 1980-01-22 | Pfizer Inc. | L- and DL- Phenylglycines to treat diseases or conditions attributable to reduced carbohydrate metabolism |
| USPP4199P (en) | 1977-01-18 | 1978-01-24 | B. L. Cobia, Inc. | Milkweed plant family |
| DE2719912C3 (de) * | 1977-05-04 | 1979-12-06 | Bayer Ag, 5090 Leverkusen | Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen |
| US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
| NO154918C (no) * | 1977-08-27 | 1987-01-14 | Bayer Ag | Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin. |
| JPS5953920B2 (ja) * | 1977-12-28 | 1984-12-27 | 東洋醸造株式会社 | 新規なアミノ糖化合物およびその製法 |
| IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
| US4273763A (en) | 1978-01-23 | 1981-06-16 | Efamol Limited | Pharmaceutical and dietary compositions |
| JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
| JPS5740478A (en) * | 1980-08-22 | 1982-03-06 | Ono Pharmaceut Co Ltd | Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative |
| US4791126A (en) * | 1980-08-22 | 1988-12-13 | Ono Pharmaceutical Co., Ltd. | Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredients |
| DE3166093D1 (en) * | 1981-01-05 | 1984-10-18 | Takeda Chemical Industries Ltd | N-substituted pseudo-aminosugars, their production and use |
| CA1176269A (en) * | 1981-03-02 | 1984-10-16 | Kazimir Sestanj | N-naphthoylglycine derivatives |
| US4377500A (en) | 1981-07-08 | 1983-03-22 | The Standard Oil Co. | Catalysts |
| US4438272A (en) * | 1982-04-15 | 1984-03-20 | Alcon Laboratories, Inc. | Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones |
| US4436745A (en) * | 1982-04-15 | 1984-03-13 | Alcon Laboratories, Inc. | Method of inhibiting aldose reductase activity |
| JPS58194818A (ja) | 1982-05-10 | 1983-11-12 | Iwasaki Shuzo | サボテン中の水溶性多糖及び繊維の取得方法 |
| ES8404693A1 (es) | 1982-08-12 | 1984-05-01 | Nativelle Sa Ets | Procedimiento de preparacion de nuevos amino-14 esteroides. |
| AU570439B2 (en) | 1983-03-28 | 1988-03-17 | Compression Labs, Inc. | A combined intraframe and interframe transform coding system |
| HU201675B (en) | 1983-08-26 | 1990-12-28 | Ivan Balkanyi | Process for producing oral pharmaceutical compositions with unappetizing effect |
| US5066659A (en) * | 1984-10-30 | 1991-11-19 | Pfizer Inc. | Spiro-heteroazalones for treatment of diabetic complications |
| US4634765A (en) * | 1984-12-18 | 1987-01-06 | Merrell Dow Pharmaceuticals Inc. | Homodisaccharide hypoglycemic agents |
| US5246960A (en) | 1984-12-21 | 1993-09-21 | Hoffmann-La Roche Inc. | Oxetanones |
| CA1270837A (en) | 1984-12-21 | 1990-06-26 | Hoffmann-La Roche Limited | Oxetanones |
| IT1207504B (it) | 1985-09-26 | 1989-05-25 | Crinos Industria Farmaco | Composizione moderatrice dell'appetito ed antigastrica. |
| IT1190400B (it) | 1985-10-04 | 1988-02-16 | Istituto Biochimico Italiano | Derivati dell'acido 19,20-bis,nor-prostanoico ad attivita' antiulcera e anoressivca,procedimento per la loro preparazione e composizioni farmaceutiche |
| GB8524663D0 (en) * | 1985-10-07 | 1985-11-13 | Fujisawa Pharmaceutical Co | Quinazoline derivatives |
| US4939140A (en) * | 1985-11-07 | 1990-07-03 | Pfizer Inc. | Heterocyclic oxophthalazinyl acetic acids |
| US4757151A (en) | 1985-11-14 | 1988-07-12 | Warner-Lambert Company | 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl] |
| US4652553A (en) * | 1985-11-25 | 1987-03-24 | Merck & Co., Inc. | Steroidal glycolipids as host resistance stimulators |
| GB8600489D0 (en) | 1986-01-09 | 1986-02-12 | Erba Farmitalia | Aminoglycoside steroids |
| AU602641B2 (en) * | 1986-04-17 | 1990-10-18 | Senju Pharmaceutical Co., Ltd. | Thiolactam-N-acetic acid derivatives, their production and use |
| DE3769066D1 (de) | 1986-08-28 | 1991-05-08 | Sanwa Kagaku Kenkyusho Co | Hydantoin-derivate zur behandlung von komplikationen bei diabetes. |
| ZA883929B (en) | 1987-06-22 | 1990-02-28 | Hoffmann La Roche | Cholecystokinin analogs for controlling appetite |
| US5175154A (en) * | 1987-11-25 | 1992-12-29 | Research Corporation Technologies, Inc. | 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds |
| US5192772A (en) * | 1987-12-09 | 1993-03-09 | Nippon Shinyaku Co. Ltd. | Therapeutic agents |
| GB8801037D0 (en) * | 1988-01-18 | 1988-02-17 | Plessey Co Ltd | Improvements relating to fuel supply systems |
| US5252572A (en) * | 1988-02-03 | 1993-10-12 | Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. | Pyridopyrimidine derivatives, pharmaceutical compositions containing them and process for preparing same |
| EP0344383A1 (en) * | 1988-06-02 | 1989-12-06 | Merrell Dow Pharmaceuticals Inc. | Novel alpha-Glucosidase inhibitors |
| DE3836675A1 (de) * | 1988-10-28 | 1990-05-03 | Hoechst Ag | Glykosidase-inhibitor salbostatin, verfahren zu seiner herstellung und seine verwendung |
| US4978669A (en) | 1989-06-08 | 1990-12-18 | Neurex Corporation | Method of suppressing appetite by administration of tetrahydro-beta-carboline derivatives |
| JPH03120227A (ja) | 1989-10-02 | 1991-05-22 | Shigeo Ochi | 飲食物消化分解産物吸収抑制剤 |
| US4980357A (en) * | 1990-03-01 | 1990-12-25 | Pfizer Inc. | Azolidinedione derivatives |
| US5037831A (en) * | 1990-05-21 | 1991-08-06 | American Home Products Corporation | Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors |
| US5504078A (en) * | 1990-06-08 | 1996-04-02 | Merrell Dow Pharmaceuticals Inc. | α-glucosidase inhibitors |
| GB9016978D0 (en) * | 1990-08-02 | 1990-09-19 | Ici Plc | Acetamide derivatives |
| US5217877A (en) * | 1990-09-28 | 1993-06-08 | Bristol-Myers Squibb Company | Process for the preparation of α-glucosidase inhibitor, pradimicin Q |
| US5091418A (en) * | 1990-09-28 | 1992-02-25 | Bristol-Myers Squibb Company | Novel alpha-glucosidase inhibitor, pradimicin Q |
| US6100048A (en) * | 1992-04-10 | 2000-08-08 | Oregon Health Sciences University | Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals |
| KR950703539A (ko) * | 1992-09-28 | 1995-09-20 | 알렌 제이. 스피겔 | 당뇨병 합병증 치료용 치환된 피리미딘(substituted pyrimidines for control or diabetic complications) |
| CZ285021B6 (cs) | 1992-09-30 | 1999-05-12 | Motorola, Inc. | Způsob a systém pro spolehlivé doručování zpráv |
| GB9307833D0 (en) | 1993-04-15 | 1993-06-02 | Glaxo Inc | Modulators of cholecystokinin and gastrin |
| FR2706255B1 (fr) | 1993-06-17 | 1995-10-27 | Univ Rennes | Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques. |
| AU7174494A (en) | 1993-06-18 | 1995-01-17 | University Of Cincinnati, The | Neuropeptide y antagonists and agonists |
| US5516516A (en) | 1993-10-19 | 1996-05-14 | Cherksey; Bruce D. | Method of preparing muira puama extract and its use for decreasing body fat percentage and increasing lean muscle mass |
| JPH07184548A (ja) * | 1993-12-28 | 1995-07-25 | Meiji Seito Kk | 口腔用組成物 |
| US6309853B1 (en) * | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| US5698199A (en) | 1995-03-10 | 1997-12-16 | Kao Corporation | Lipolysis acceleration method |
| MX9709874A (es) | 1995-06-06 | 1998-03-31 | Pfizer | N-(INDOL-2-CARBONIL) beta-ALANILAMIDAS SUSTITUIDAS Y DERIVADOS COMO INHIBIDORES DE GLUCOGENO FOSFORILASA, USO DE LOS MISMOS Y COMPOSICIONES QUE LOS CONTIENEN. |
| DE69523182T2 (de) | 1995-06-06 | 2002-02-07 | Pfizer | Substituierte n-(indol-2-carbonyl)-glycinamide und derivate als glycogen phosphorylase inhibitoren |
| JPH08332028A (ja) | 1995-06-12 | 1996-12-17 | Takashi Mizuno | サボテン成分入り冷菓とその製法 |
| US5693327A (en) | 1995-07-12 | 1997-12-02 | Shah; Eladevi | Herbal compositions |
| EP0862631A1 (en) | 1995-10-26 | 1998-09-09 | The Board Of Regents, The University Of Texas System | Luminal cholecystokinin-releasing factor |
| US5824668A (en) | 1996-11-07 | 1998-10-20 | Supergen, Inc. | Formulation for administration of steroid compounds |
| TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| US5908609A (en) | 1996-06-10 | 1999-06-01 | Millennium Pharmaceuticals, Inc. | Screening methods for compounds useful in the regulation of body weight |
| US5932779A (en) * | 1996-06-10 | 1999-08-03 | Millennium Pharmaceuticals, Inc. | Screening methods for compounds useful in the regulation of body weight |
| WO1998020121A1 (en) | 1996-11-06 | 1998-05-14 | Children's Medical Center Corporation | Transgenic animal expressing a syndecan in the regions of hypothalamus |
| EP0946595A2 (en) * | 1996-12-17 | 1999-10-06 | Quadrant Holdings Cambridge Limited | Melanocortins |
| CA2217698A1 (en) | 1996-12-20 | 1998-06-20 | Eli Lilly And Company | Anti-obesity proteins |
| US5798101A (en) | 1997-01-22 | 1998-08-25 | Hpf, L.L.C. | Herbal appetite suppressant and weight loss composition |
| JP2002538757A (ja) | 1997-03-26 | 2002-11-12 | ノボ ノルディスク アクティーゼルスカブ | 食欲制御活性を有するポリペプチド |
| HUP0000838A3 (en) * | 1997-04-15 | 2001-04-28 | Csir | Extract containing steroid-glucosid, process for its isolation and synthesis, pharmaceutical composition containing it having appetite suppressant activity |
| FR2771105A1 (fr) | 1997-11-20 | 1999-05-21 | Vitasterol | Utilisation du fusarium monoliforme pour la preparation des derives 7alpha-hydroxyles de la dehydroepiandrosterone et de la pregnenolone |
| GB2355657B (en) * | 1999-10-27 | 2004-07-28 | Phytopharm Plc | Inhibitors Of Gastric Acid Secretion |
| GB2363985B (en) * | 2000-06-30 | 2004-09-29 | Phytopharm Plc | Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use |
-
1998
- 1998-04-15 HU HU0000838A patent/HUP0000838A3/hu unknown
- 1998-04-15 SK SK1418-99A patent/SK141899A3/sk unknown
- 1998-04-15 UA UA99116170A patent/UA72439C2/uk unknown
- 1998-04-15 AP APAP/P/2003/002730A patent/AP2003002730A0/en unknown
- 1998-04-15 PL PL380957A patent/PL201487B1/pl not_active IP Right Cessation
- 1998-04-15 BR BR9808593-0A patent/BR9808593A/pt not_active Application Discontinuation
- 1998-04-15 ES ES05017768T patent/ES2363230T3/es not_active Expired - Lifetime
- 1998-04-15 SG SG200106269A patent/SG120054A1/en unknown
- 1998-04-15 PL PL98336498A patent/PL196015B1/pl not_active IP Right Cessation
- 1998-04-15 AT AT98917372T patent/ATE344046T1/de active
- 1998-04-15 MY MYPI98001667A patent/MY141674A/en unknown
- 1998-04-15 ES ES98917372T patent/ES2276460T3/es not_active Expired - Lifetime
- 1998-04-15 GB GB9919797A patent/GB2338235B/en not_active Expired - Fee Related
- 1998-04-15 CN CNA2008100057269A patent/CN101239090A/zh active Pending
- 1998-04-15 ES ES02004101T patent/ES2321162T3/es not_active Expired - Lifetime
- 1998-04-15 PT PT02004101T patent/PT1213020E/pt unknown
- 1998-04-15 CN CNB988041650A patent/CN100378118C/zh not_active Expired - Fee Related
- 1998-04-15 DE DE69840552T patent/DE69840552D1/de not_active Expired - Lifetime
- 1998-04-15 TR TR2000/01846T patent/TR200001846T2/xx unknown
- 1998-04-15 EP EP04002070A patent/EP1438965A1/en not_active Withdrawn
- 1998-04-15 NZ NZ516696A patent/NZ516696A/en unknown
- 1998-04-15 IL IL13165998A patent/IL131659A/xx not_active IP Right Cessation
- 1998-04-15 GB GB0117039A patent/GB2360519B/en not_active Expired - Fee Related
- 1998-04-15 AP APAP/P/1999/001673A patent/AP1291A/en active
- 1998-04-15 ZA ZA9803170A patent/ZA983170B/xx unknown
- 1998-04-15 EP EP02004100.0A patent/EP1222927B1/en not_active Expired - Lifetime
- 1998-04-15 AU AU70613/98A patent/AU746414B2/en not_active Ceased
- 1998-04-15 NZ NZ516695A patent/NZ516695A/en unknown
- 1998-04-15 NZ NZ337422A patent/NZ337422A/en unknown
- 1998-04-15 TR TR1999/02540T patent/TR199902540T2/xx unknown
- 1998-04-15 CN CNA2008100057254A patent/CN101239089A/zh active Pending
- 1998-04-15 EA EA200200392A patent/EA200200392A1/ru unknown
- 1998-04-15 PL PL374521A patent/PL197783B1/pl not_active IP Right Cessation
- 1998-04-15 EP EP02004101A patent/EP1213020B1/en not_active Expired - Lifetime
- 1998-04-15 EP EP05017768A patent/EP1598054B1/en not_active Expired - Lifetime
- 1998-04-15 NZ NZ525021A patent/NZ525021A/en unknown
- 1998-04-15 AT AT05017768T patent/ATE502041T1/de not_active IP Right Cessation
- 1998-04-15 DK DK98917372T patent/DK0973534T3/da active
- 1998-04-15 CA CA002584411A patent/CA2584411A1/en not_active Abandoned
- 1998-04-15 US US09/402,962 patent/US6376657B1/en not_active Expired - Lifetime
- 1998-04-15 EE EEP199900497A patent/EE9900497A/et unknown
- 1998-04-15 GE GEAP19985030A patent/GEP20022709B/en unknown
- 1998-04-15 DE DE69842189T patent/DE69842189D1/de not_active Expired - Lifetime
- 1998-04-15 GE GEAP19985544A patent/GEP20022788B/en unknown
- 1998-04-15 AT AT02004101T patent/ATE422359T1/de active
- 1998-04-15 DE DE69836321T patent/DE69836321T2/de not_active Expired - Lifetime
- 1998-04-15 KR KR10-2003-7005297A patent/KR100510614B1/ko not_active IP Right Cessation
- 1998-04-15 YU YU52199A patent/YU52199A/sh unknown
- 1998-04-15 KR KR1019997009513A patent/KR100891756B1/ko not_active IP Right Cessation
- 1998-04-15 NZ NZ525022A patent/NZ525022A/en unknown
- 1998-04-15 IL IL15846698A patent/IL158466A0/xx unknown
- 1998-04-15 WO PCT/GB1998/001100 patent/WO1998046243A2/en active Application Filing
- 1998-04-15 CA CA002283564A patent/CA2283564C/en not_active Expired - Fee Related
- 1998-04-15 GB GB0117041A patent/GB2360520B/en not_active Expired - Fee Related
- 1998-04-15 AP APAP/P/2003/002729A patent/AP2003002729A0/en unknown
- 1998-04-15 EP EP98917372A patent/EP0973534B1/en not_active Expired - Lifetime
- 1998-04-15 IL IL15846598A patent/IL158465A0/xx unknown
- 1998-04-15 PT PT98917372T patent/PT973534E/pt unknown
- 1998-04-15 EA EA199900932A patent/EA002885B1/ru not_active IP Right Cessation
- 1998-04-15 JP JP54363398A patent/JP3553086B2/ja not_active Expired - Fee Related
- 1998-04-15 ID IDW991200A patent/ID22888A/id unknown
- 1998-06-02 TW TW091137165A patent/TW589187B/zh not_active IP Right Cessation
- 1998-06-02 TW TW087108667A patent/TW539551B/zh active
- 1998-06-02 TW TW091137164A patent/TWI253932B/zh not_active IP Right Cessation
- 1998-06-09 GT GT199800076BL patent/GT199800076BA/es unknown
- 1998-06-09 PE PE1998000485A patent/PE85699A1/es not_active Application Discontinuation
- 1998-06-09 GT GT199800076A patent/GT199800076A/es unknown
- 1998-06-09 GT GT199800076AK patent/GT199800076AA/es unknown
- 1998-09-06 SA SA98190501A patent/SA98190501B1/ar unknown
-
1999
- 1999-09-24 IS IS5196A patent/IS5196A/is unknown
- 1999-10-08 OA OA9900225A patent/OA11166A/en unknown
- 1999-10-11 BG BG103795A patent/BG103795A/xx unknown
- 1999-10-14 NO NO994992A patent/NO994992L/no not_active Application Discontinuation
-
2000
- 2000-09-14 HK HK00105778A patent/HK1026373A1/xx not_active IP Right Cessation
-
2002
- 2002-01-10 JP JP2002003897A patent/JP2002205997A/ja active Pending
- 2002-02-13 US US10/073,357 patent/US20020168427A1/en not_active Abandoned
- 2002-06-14 US US10/170,750 patent/US20030086984A1/en not_active Abandoned
- 2002-06-25 JP JP2002184593A patent/JP2003026591A/ja active Pending
-
2004
- 2004-06-22 US US10/872,567 patent/US7166611B2/en not_active Expired - Fee Related
- 2004-06-22 US US10/872,463 patent/US20040234634A1/en not_active Abandoned
-
2006
- 2006-02-28 US US11/363,057 patent/US20060205931A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE9900497A (et) | Söögiisu pärssiva toimega farmatseutilised kompositsioonid | |
| IS5046A (is) | Lyfjasamsetningar | |
| NO995925D0 (no) | Farmasöytiske sammensetninger omfattende cyklodekstriner | |
| ID27415A (id) | Komposisi farmaseutik | |
| IS4706A (is) | Lyfjasamsetningar | |
| EE9900055A (et) | Farmatseutilised aerosoolkompositsioonid | |
| FR2775596B1 (fr) | Nouvelles compositions pharmaceutiques | |
| ID18352A (id) | Komposisi-komposisi farmasi | |
| ID29262A (id) | Komposisi farmasi | |
| ID27201A (id) | Komposisi farmasi | |
| NO993460D0 (no) | Paroxetine-preparater | |
| IS2515B (is) | Lyfjasamsetningar | |
| EE200000330A (et) | Farmatseutilised kompositsioonid | |
| MA26531A1 (fr) | Composition pharmaceutique | |
| PT941100E (pt) | Composicoes farmaceuticas | |
| ITMI942166A0 (it) | Composizioni farmaceutiche miorilassanti | |
| FR2779145B1 (fr) | Nouvelles compositions pharmaceutiques | |
| IS2200B (is) | Lyfjasamsetningar | |
| NO994436L (no) | Farmasöytiske sammensetninger | |
| FI962738A0 (fi) | Farmaseuttiset koostumukset | |
| BR1100755A (pt) | composição farmacêutica | |
| SE9800330D0 (sv) | Pharmaceutical compositions | |
| SE9800052D0 (sv) | Pharmaceutical compositions | |
| FI981567A0 (fi) | Farmaseuttiset koostumukset | |
| DK1037604T3 (da) | Farmaceutiske aerosolsammensætninger |